sportradar-logo(2).jpg
Alpha Odds da Sportradar Aumentou os Lucros em 15% para os Operadores nas Partidas Classificatórias da UEFA Euro 2024
May 13, 2024 03:20 ET | Sportradar AG
ST. GALLEN, Suíça, May 13, 2024 (GLOBE NEWSWIRE) -- A Alpha Odds da Sportradar (NASDAQ: SRAD), a tecnologia de probabilidades personalizadas baseada em IA aumentou os lucros dos operadores...
sportradar-logo(2).jpg
Sportradar’s Alpha Odds Increased Profits By 15% for Operators Across UEFA Euro 2024 Qualifying Matches
May 13, 2024 03:16 ET | Sportradar AG
ST. GALLEN, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Odds, Sportradar’s (NASDAQ: SRAD) AI-driven personalised odds technology, boosted profits for sportsbook operators by an average of...
iTeos Logo 2022.png
iTeos meldet Finanzergebnisse für das erste Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt
May 11, 2024 13:31 ET | iTeos Therapeutics Inc.
- Belrestotug + Dostarlimab übertraf die vordefinierten Wirksamkeitskriterien für klinisch relevante Aktivität, die in einer Zwischenbewertung der Phase 2 von GALAXIES Lung-201 beobachtet wurde -...
iTeos Logo 2022.png
iTeos fait le point sur ses activités et publie ses résultats financiers pour le premier trimestre 2024
May 11, 2024 13:31 ET | iTeos Therapeutics Inc.
- Le doublet belrestotug + dostarlimab a dépassé les critères d’efficacité prédéfinis pour une activité cliniquement pertinente constatée lors d’une évaluation intérimaire de Phase 2 sur GALAXIES...
iTeos Logo 2022.png
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024 08:26 ET | iTeos Therapeutics Inc.
- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201- Clinically meaningful tumor...
UTR Sports Selects S
UTR Sports Selects Sportradar in Long Term, Wide-ranging Partnership
May 09, 2024 08:30 ET | UTR Sports
Palo Alto, Calif. and St. Gallen, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- UTR Sports today announced a long-term partnership with Sportradar (NASDAQ: SRAD) to transform fan and bettor...
sportradar-logo(2).jpg
Sportradar to Participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 21
May 09, 2024 08:00 ET | Sportradar AG
ST. GALLEN, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company, today announced that Carsten...
22157.jpg
Australia Rail Signalling Market 2024-2030 - Size, Trends, Segmentation, Revenue, Outlook, Companies, Share, Growth, Analysis, Value, Industry & Forecast
May 08, 2024 06:05 ET | Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Australia Rail Signalling Market 2024-2030 Size, Trends, Segmentation, Revenue, Outlook, Companies, Share, Growth, Analysis, Value, Industry &...
inozyme_logo.jpg
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 07, 2024 08:30 ET | Inozyme Pharma Inc.
Inozyme reported financial results for the first quarter ended March 31, 2024 and provided business highlights.
Esperion Logo (primary).png
Esperion Reports First Quarter 2024 Financial Results
May 07, 2024 06:00 ET | Esperion Therapeutics, Inc.
– Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally – – Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million – – Q1 Retail Prescription Equivalents Grew 43%...